FDA
-
-
-
-
-
-
-
Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026
-
-
-
-
-
-
-
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
-
-
-
-
-
-
-
Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
-
-
-
-
-
-
-
Journey Medical to Join Russell 2000® and Russell 3000® Indexes
-
-
-
-
-
-
-
Journey Medical Corp (DERM) Appoints Ramsey Alloush as COO
-
-
-
-
-
-
-
Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea
-
-
-
-
-
-
-
Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference
-
330,175 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

